Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test
Gespeichert in:
| Veröffentlicht in: | Nature reviews. Neurology 2017-02, Vol.13 (2), p.74-76 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 76 |
|---|---|
| container_issue | 2 |
| container_start_page | 74 |
| container_title | Nature reviews. Neurology |
| container_volume | 13 |
| creator | Reiman, Eric M |
| description | |
| doi_str_mv | 10.1038/nrneurol.2017.1 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1861470777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A479602113</galeid><sourcerecordid>A479602113</sourcerecordid><originalsourceid>FETCH-LOGICAL-g322t-36b81685c045485b6013241b3dfecd376bee1c4349e17a547aeb1d32043e55cd3</originalsourceid><addsrcrecordid>eNptkctLAzEQxoMovs_eJCCIl9a8Nkm9lfpEQQ96XrK70za6m2iSPehfb4r1icxhhuE333zMILRHyZASro9dcNAH3w4ZoWpIV9AmVcVoIJSUq191oTfQVoyPhEjJGV1HG0wTLTiTm-h63L7NwXYQcGMjmAjYOpzV5Am-61OybobHpzgFMKkDlyI2rsGV9Z0JTxAiTh6nOeAEMe2gtalpI-wu8zZ6OD-7n1wObm4vribjm8GMM5YGXFaaSl3URBRCF5UklDNBK95MoW64khUArQUXI6DKFEIZqGjDGREciiIT2-joQ_c5-Jc-Ly47G2toW-PA97GkWlKhiFIqowd_0EffB5fdLah8DMaE_qZmpoXSuqlPwdQL0XIs1EgSRinP1PAfKkcDna29g6nN_V8Dhz8G5mDaNI--7ZP1Lv4G95cu-6qDpnwONp_3tfx8E38HRXiQLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1863212248</pqid></control><display><type>article</type><title>Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Reiman, Eric M</creator><creatorcontrib>Reiman, Eric M</creatorcontrib><identifier>ISSN: 1759-4758</identifier><identifier>EISSN: 1759-4766</identifier><identifier>DOI: 10.1038/nrneurol.2017.1</identifier><identifier>PMID: 28084326</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Aging ; Alzheimer Disease - diagnosis ; Alzheimer Disease - therapy ; Alzheimer's disease ; Antibodies ; Automation ; Biomarkers ; Biomarkers - analysis ; Care and treatment ; Clinical trials ; Cognitive ability ; Dementia ; Diagnosis ; Disease ; Humans ; Hypotheses ; Medical research ; Prevention ; Proteins ; Webcasting</subject><ispartof>Nature reviews. Neurology, 2017-02, Vol.13 (2), p.74-76</ispartof><rights>COPYRIGHT 2017 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Feb 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28084326$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reiman, Eric M</creatorcontrib><title>Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test</title><title>Nature reviews. Neurology</title><addtitle>Nat Rev Neurol</addtitle><subject>Aging</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - therapy</subject><subject>Alzheimer's disease</subject><subject>Antibodies</subject><subject>Automation</subject><subject>Biomarkers</subject><subject>Biomarkers - analysis</subject><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Diagnosis</subject><subject>Disease</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Medical research</subject><subject>Prevention</subject><subject>Proteins</subject><subject>Webcasting</subject><issn>1759-4758</issn><issn>1759-4766</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkctLAzEQxoMovs_eJCCIl9a8Nkm9lfpEQQ96XrK70za6m2iSPehfb4r1icxhhuE333zMILRHyZASro9dcNAH3w4ZoWpIV9AmVcVoIJSUq191oTfQVoyPhEjJGV1HG0wTLTiTm-h63L7NwXYQcGMjmAjYOpzV5Am-61OybobHpzgFMKkDlyI2rsGV9Z0JTxAiTh6nOeAEMe2gtalpI-wu8zZ6OD-7n1wObm4vribjm8GMM5YGXFaaSl3URBRCF5UklDNBK95MoW64khUArQUXI6DKFEIZqGjDGREciiIT2-joQ_c5-Jc-Ly47G2toW-PA97GkWlKhiFIqowd_0EffB5fdLah8DMaE_qZmpoXSuqlPwdQL0XIs1EgSRinP1PAfKkcDna29g6nN_V8Dhz8G5mDaNI--7ZP1Lv4G95cu-6qDpnwONp_3tfx8E38HRXiQLw</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Reiman, Eric M</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201702</creationdate><title>Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test</title><author>Reiman, Eric M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g322t-36b81685c045485b6013241b3dfecd376bee1c4349e17a547aeb1d32043e55cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aging</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - therapy</topic><topic>Alzheimer's disease</topic><topic>Antibodies</topic><topic>Automation</topic><topic>Biomarkers</topic><topic>Biomarkers - analysis</topic><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Diagnosis</topic><topic>Disease</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Medical research</topic><topic>Prevention</topic><topic>Proteins</topic><topic>Webcasting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reiman, Eric M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reiman, Eric M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test</atitle><jtitle>Nature reviews. Neurology</jtitle><addtitle>Nat Rev Neurol</addtitle><date>2017-02</date><risdate>2017</risdate><volume>13</volume><issue>2</issue><spage>74</spage><epage>76</epage><pages>74-76</pages><issn>1759-4758</issn><eissn>1759-4766</eissn><cop>England</cop><pub>Nature Publishing Group</pub><pmid>28084326</pmid><doi>10.1038/nrneurol.2017.1</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1759-4758 |
| ispartof | Nature reviews. Neurology, 2017-02, Vol.13 (2), p.74-76 |
| issn | 1759-4758 1759-4766 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1861470777 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Aging Alzheimer Disease - diagnosis Alzheimer Disease - therapy Alzheimer's disease Antibodies Automation Biomarkers Biomarkers - analysis Care and treatment Clinical trials Cognitive ability Dementia Diagnosis Disease Humans Hypotheses Medical research Prevention Proteins Webcasting |
| title | Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A30%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alzheimer%20disease%20in%202016:%20Putting%20AD%20treatments%20and%20biomarkers%20to%20the%20test&rft.jtitle=Nature%20reviews.%20Neurology&rft.au=Reiman,%20Eric%20M&rft.date=2017-02&rft.volume=13&rft.issue=2&rft.spage=74&rft.epage=76&rft.pages=74-76&rft.issn=1759-4758&rft.eissn=1759-4766&rft_id=info:doi/10.1038/nrneurol.2017.1&rft_dat=%3Cgale_proqu%3EA479602113%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1863212248&rft_id=info:pmid/28084326&rft_galeid=A479602113&rfr_iscdi=true |